160 related articles for article (PubMed ID: 22576960)
1. Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
Weltermann A; Brodmann M; Domanovits H; Eber B; Gottsauner-Wolf M; Halbmayer WM; Hiesmayr JM; Kyrle PA; Längle F; Roithinger FX; Watzke H; Windhager R; Wolf C; Zweiker R
Wien Klin Wochenschr; 2012 May; 124(9-10):340-7. PubMed ID: 22576960
[TBL] [Abstract][Full Text] [Related]
2. Management of dabigatran-induced bleeding: expert statement.
Fries D; Giurea A; Gütl M; Halbmayer WM; Kozek-Langenecker S; Pachucki A; Roithinger F; Steinlechner B; Thaler H; Weltermann A
Wien Klin Wochenschr; 2013 Nov; 125(21-22):721-9. PubMed ID: 24217941
[TBL] [Abstract][Full Text] [Related]
3. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C
Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Brunetti L; Chen C; White J
Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
[TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
Averkov OV
Kardiologiia; 2011; 51(7):53-7. PubMed ID: 21878086
[No Abstract] [Full Text] [Related]
7. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation.
Moore CH; Snashall J; Boniface K; Scott J
Am J Emerg Med; 2012 Nov; 30(9):2082.e1-2. PubMed ID: 22196949
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
[TBL] [Abstract][Full Text] [Related]
10. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM;
Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
12. The use of dabigatran immediately after atrial fibrillation ablation.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
14. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
Zotova IV; Zateĭshchikov DA
Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
[No Abstract] [Full Text] [Related]
15. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T; Sairaku A; Yoshida Y; Kamiya H; Tatematsu Y; Nanasato M; Inden Y; Hirayama H; Murohara T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):172-9. PubMed ID: 23121681
[TBL] [Abstract][Full Text] [Related]
16. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
Augoustides JG
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
[TBL] [Abstract][Full Text] [Related]
18. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
19. [Update on current care guidelines: atrial fibrillation].
Käypä hoito -suosituksen päivitystiivistelmä
Duodecim; 2012; 128(4):374-6. PubMed ID: 22448550
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Lillo-Le Louët A; Wolf M; Soufir L; Galbois A; Dumenil AS; Offenstadt G; Samama MM
Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
